Brochure | May 2, 2022

In The Fight To Bring Innovative Therapies To Patients

Source: Worldwide Clinical Trials
GettyImages-1304430076 oncology ps

Building risk assessments and monitoring plans that focus on what is important into trial design lays the groundwork for a successful drug program by increasing data integrity and safeguarding patients. Our risk-based quality management (RBQM) capabilities ensure that:

  • Risks to critical data and processes are identified early
  • Functional areas each have unique and defined monitoring strategies
  • A validated, closed system (TRI OPRA) manages the process with access control and a full audit trail
  • A risk log that gives the option to add integrated forward looking indicators for Central Monitoring of potential risks in near real time

Download the available brochure to learn more.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader